Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies.
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies. Future Oncol. 2024; 20(27):1983-1991.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Humans
Neoplasms
authors with profiles
Marina Chiara Garassino